RUSSELL MCALVAIN: Open Payments
NPI 1447966411 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,767 in 106 payments from 16 companies in 2025. Trend: 2023 $1,066 · 2024 $1,225 · 2025 $1,767
Food & beverage: $1,767
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $285 |
| PFIZER INC. | 18 | $248 |
| Lilly USA, LLC | 12 | $170 |
| GlaxoSmithKline, LLC. | 17 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $140 |
| ABBVIE INC. | 13 | $139 |
| Novo Nordisk Inc | 15 | $137 |
| Abbott Laboratories | 2 | $132 |
| Aimmune Therapeutics, Inc. | 2 | $80 |
| Radius Health, Inc. | 3 | $74 |
Products named: JARDIANCE, AIRSUPRA, FREESTYLE LIBRE 3, PREVNAR 20, FARXIGA, MOUNJARO, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across OK — which companies pay providers there.
